Incidental Detection of Colon Cancer by FDG Positron Emission Tomography in Patients Examined for Pulmonary Nodules

Clinical Nuclear Medicine

Volumn 27, Issue 9, 2002, Pages 628-632

  Zhuang, Hongming ^a   Hickeson, Marc ^a   Chacko, Thomas K ^a   Duarte, Paulo S ^b   Nakhoda, Khozaim Z ^a   Feng, Qi ^a   Alavi, Abass ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b Fleury Laboratory   (Brazil)

Author keywords

Colon Cancer; Fluorodeoxyglucose; Positron Emission Tomography; Pulmonary Nodule

Indexed keywords

FLUORODEOXYGLUCOSE; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; CANCER INCIDENCE; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE COURSE; DRUG UPTAKE; FEMALE; GASTROINTESTINAL TRACT; HUMAN; INCIDENTAL FINDING; LUNG CANCER; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OCCULT CANCER; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; REVIEW; SENSITIVITY AND SPECIFICITY; TISSUE SECTION; ADENOCARCINOMA; ADENOMA; ARTICLE; BIOPSY; COLON TUMOR; COLONOSCOPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; LUNG COIN LESION; METHODOLOGY; MIDDLE AGED; MULTIPLE CANCER; PATHOLOGY; SCINTISCANNING; SIGMOIDOSCOPY;

ADENOCARCINOMA; ADENOMA; BIOPSY; COIN LESION, PULMONARY; COLONIC NEOPLASMS; COLONOSCOPY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SIGMOIDOSCOPY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036729887     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200209000-00004     Document Type: Review

References (20)

1. Conti PS, Lilien DL, Hawley K, et al: PET and [18F]-FDG in oncology: a clinical update. Nucl Med Biol 23:717, 1996.
2. Hoh CK, Schiepers C, Seltzer MA, et al: PET in oncology: Will it replace the other modalities? Semin Nucl Med 27:94, 1997.
3. Hustinx R, Alavi A: Whole-body FDG-PET Imaging in the management of patients with cancer. Semin Nucl Med 32:35, 2002.
4. Erasmus JJ, McAdams HP, Patz EF Jr, et al: Thoracic FDG PET: state of the art. Radiographics 18:5, 1998.
5. Vansteenkiste JF, Stroobants SG: The role of positron emission tomography with F-18-fluoro-2-deoxy-D-glucose in respiratory oncology. Eur Respir J 17:802, 2001.
6. Lee J, Aronchick JM, Alavi A: Accuracy of F-18 fluorodeoxyglucose positron emission tomography for the evaluation malignancy in patients presenting with new lung abnormalities: a retrospective review. Chest 120:1791, 2001.
7. Karp JS, Muehllehner G, Qu H, et al: Singles transmission in volume-imaging PET with a 137Cs source. Phys Med Biol 40: 929, 1995.
8. Bedigian MP, Benard F, Smith RJ, et al: Whole-body positron emission tomography for oncology imaging using singles transmission scanning with segmentation and ordered subsets expectation maximization (OS-EM) reconstruction. Eur J Nucl Med 25:659, 1998.
9. Gupta N, Bradfield H: Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms. Semin Nucl Med 26:65, 1996.
10. Findlay M, Young H, Cunningham D, et al: Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. J Clin Oncol 14: 700, 1996.
11. Abdel-Nabi H, Doerr RJ, Lamonica DM, et al: Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 206:755, 1998.
12. Staib L, Schirrmeister H, Reske SN, et al: Is F-18-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making? Am J Surg 180:1, 2000.
13. Whiteford MH, Whiteford HM, Yee LF, et al: Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 43:759, 2000.
14. Zhuang H, Sinha P, Pourdehnad M, et al: The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver. Nucl Med Commun 21:793, 2000.
15. Patel SA, Zenilman ME: Outcomes in older people undergoing operative intervention for colorectal cancer. J Am Geriatr Soc 49:1561, 2001.
16. Zhuang H, Duarte PS, Pourdehnad M, et al: Standardized uptake value as an unreliable index of renal disease on FDG-PET imaging. Clin Nucl Med 25:358, 2000.
17. Meyer MA: Diffusely increased colonic F-18 FDG uptake in acute enterocolitis. Clin Nucl Med 20:434, 1995.
18. Hannah A, Scott AM, Akhurst T, et al: Abnormal colonic accumulation of fluorine-18-FDG in pseudomembranous colitis. J Nucl Med 37:1683, 1996.
19. Jacobson K, Mernagh JR, Green T, et al: Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Gastroenterology 116:A742, 1999.
20. Yasuda S, Ide M, Takagi S, et al: F-18 FDG uptake in colonic adenoma. Clin Nucl Med 23:99, 1998.